Clinical Trials Directory

Trials / Completed

CompletedNCT05902364

Systane® Ultra Preservative Free Lubricant Eye Drops

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
69 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this post-market clinical follow-up (PMCF) study is to assess the performance and safety of Systane Ultra Preservative-Free (PF) in subjects experiencing dry eye symptoms (Group 1) and contact lens (CL) wearers experiencing discomfort due to CL-related dryness (Group 2). Statistical analyses will be presented by group. This study will be conducted in Canada, Australia, and New Zealand.

Detailed description

Subjects will participate in the study for approximately 30 days, with a phone call scheduled on Day 15 ± 2 (Visit 2) and a follow-up visit scheduled on Day 30 ± 2 (Visit 3). Subjects will be asked to complete patient questionnaires on Day 1 and at Visit 3 (Impact of Dry Eye on Everyday Life - Symptom Bother \[IDEEL-SB\] or Contact Lens Dry Eye Questionnaire \[CLDEQ-8\] and Comfortable Wear Time questions).

Conditions

Interventions

TypeNameDescription
OTHERSystane Ultra PF lubricant eye dropsCommercially available preservative free eye drops

Timeline

Start date
2023-10-28
Primary completion
2024-08-14
Completion
2024-08-14
First posted
2023-06-15
Last updated
2025-08-27
Results posted
2025-08-27

Locations

4 sites across 2 countries: Canada, New Zealand

Source: ClinicalTrials.gov record NCT05902364. Inclusion in this directory is not an endorsement.